What's breaking now, across thousands of outlets.
Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
Key PointsBeta is participating in a program located in North Carolina.
UOB’s Quek Ser Leang and Lee Sue Ann highlight that EUR/USD extended its recent slide to 1.1358, leaving conditions deeply oversold.
At one point in July, ETFs were down $5.8 billion in net outflows for the year. Now, that’s turned into $800 million in net inflows.
KelpDAO sued LayerZero and Bryan Pellegrino over the April 18 rsETH exploit, alleging the bridge setup was endorsed in writing.
